[trx_video url=”https://www.youtube.com/watch?v=D1WZrnCcH24″ ratio=”16:9″ autoplay=”off” top=”inherit” bottom=”inherit” left=”inherit” right=”inherit”]
Always run Nagalase frequencies for viruses and cancer. Nagalase is directly proportional to tumor burden in cancer patients. Physicians recommend 10,000 units of Vitamin D a day to promote effects of GcMAF.
[trx_button type=”square” style=”filled” size=”small” align=”center” link=”https://www.frequencyfoundation.com/product/nagalase-version-2-4/” popup=”no” top=”inherit” bottom=”inherit” left=”inherit” right=”inherit”]Nagalase Frequencies[/trx_button]
Nagalase in Blood
Test for monitoring efficacy of therapy for cancer and certain viral infections
Nagalase in serum / plasma
The test measures the activity of an enzyme α-N-acetylgalactosaminidase (nagalase) in blood.
Nagalase is an extracellular matrix-degrading enzyme that is secreted by cancerous cells in the process of tumor invasion. It is also an intrinsic component of the envelope protein of various virions, such as HIV and the influenza virus. Thus, it is also secreted from virus-infected cells1,3,4.
Nagalase deglycosylates the vitamin D3-binding protein DBP (also known as Gc-protein). Gc-protein, which contains three sugars, is the precursor for the major macrophage-activating factor (MAF). By complete deglycosylation, Gc-protein can no longer be converted to MAF.
Normally, MAF is produced from the Gc-protein by sequential removal of the galactose and sialic acid without touching the remaining sugar N-acetylgalactosamine.
Macrophage activation for phagocytosis and antigen presentation is the first step in the immune development cascade. Lost precursor activity, therefore, leads to immune suppression.
Increased nagalase activity has been detected in the blood of patients with a wide variety of cancers like cancer of the prostate, breast, colon, lung, esophagus, stomach, liver, pancreas, kidney, bladder, testis, uterus, and ovary, mesothelioma, melanoma, fibrosarcoma, glioblastoma, neuroblastoma, and various leukemias1,3,4. For various types of tumors, various levels of nagalase activity were found7. It appears that the secretory capacity of individual tumor tissue varies among tumor types depending upon tumor size, staging, and the degree of malignancy or invasiveness7. Increased nagalase activity has not been detected in the blood of healthy individuals1.
Nagalase activity is directly proportional to viable tumor burden
1,2. Studies correlating nagalase levels with tumor burden suggest that the measurement of this enzyme can diagnose the presence of cancerous lesions below levels detectable by other diagnostic means
1. In research studies, nagalase activity decreased to near tumor-free control levels one day after surgical removal of primary tumors from cancer patients, suggesting that the half-life of nagalase is less than 24 hours
1,6. The short half-life of nagalase is valuable for prognosis of the disease during various therapies
1,5.
See HDRI …Here is a frequency set which could be the most useful set in your arsenal. Tim Smith, M.D. reports:
How GcMAF works: GcMAF is the protein that activates macrophages and jump-starts the entire immune response. To sabotage the immune system and put the macrophages to sleep, all cancers and viruses make Nagalese, the enzyme that blocks production of GcMAF. In the absence of GcMAF, cancers, HIV, and other viruses can grow unimpeded. Dr. Nobuto Yamamoto demonstrated that GcMAF administration bypasses the Nagalese blockage and re-activates the macrophages, which then proceed to kill the cancer cells and HIV viruses.
Frequencies are available for subscribers.